Spasmolytic Polypeptide Metaplasia
Spasmolytic Polypeptide Metaplasia - Related Videos
07:35
Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli
0 Views •
Cited by 48 •
2014
Elastin-like polypeptides are stimulus-responsive biopolymers with applications ranging from recombinant protein purification to drug delivery. This protocol describes the purification and characterization of elastin-like polypeptides and their peptide or protein fusions from Escherichia coli using their lower critical solution temperature phase transition behavior as a simple alternative to chromatography.
01:29
Spasmolytic Agents: Chemical Classification
0 Views •
2023
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells. A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
09:42
Using SecM Arrest Sequence as a Tool to Isolate Ribosome Bound Polypeptides
0 Views •
Cited by 6 •
2012
We describe here a technique that is now routinely used to isolate stably bound ribosome nascent chain complexes (RNCs). This technique takes advantage of the discovery that a 17 amino acid long SecM "arrest sequence" can halt translation elongation in a prokaryotic (E. coli) system, when inserted into (or fused to the C-terminus) of virtually any protein.
03:21
Acinar-to-Ductal Metaplasia Induction: A Method to Study Acinar Cell to Ductal Cell Differentiation in 3D Ex Vivo Culture
0 Views •
2023
This video describes the technique of differentiating pancreatic acinar cells to ductal cells in ex vivo 3D culture. This helps to understand the mechanisms regulating the acinar-to-ductal metaplasia (ADM), a key process in the early development of pancreatic cancer.
10:15
Isolation of Ribosome Bound Nascent Polypeptides in vitro to Identify Translational Pause Sites Along mRNA
0 Views •
Cited by 2 •
2012
A technique to identify translational pause sites on mRNA is described. This procedure is based on isolation of nascent polypeptides accumulating on ribosomes during in vitro translation of a target mRNA, followed by the size analysis of the nascent chains using a denaturing gel electrophoresis.
FAQs
Parietal-cell loss can alter the glandular environment. Together, tissue injury and inflammation can promote reprogramming of mature chief cells toward mucous-lineage characteristics. This relationship connects epithelial damage with metaplasia and helps explain why atrophic conditions are important in gastric cancer research and disease progression.
Trefoil factor 2 and MUC6 serve as indicators that gastric epithelial cells have acquired mucous-lineage characteristics. Measuring their expression helps investigators characterize the phenotype associated with SPEM rather than relying only on tissue injury or atrophy. These markers therefore support comparisons of cellular states during studies of repair and cancer-related remodeling.
Persistent inflammation matters because it can sustain tissue conditions accompanying parietal-cell loss, atrophy, and epithelial reprogramming. Rather than representing only a transient response to damage, ongoing inflammatory remodeling may maintain a setting associated with progression toward dysplasia. This makes SPEM relevant for examining how chronic injury may precede gastric cancer.
To investigate cellular origins, researchers can ask which gastric epithelial populations acquire mucous-lineage markers after injury and how those changes relate to chief-cell identity. They can then examine signaling pathways associated with the reprogramming process. Linking cell identity, marker expression, and tissue damage helps distinguish a repair response from changes relevant to dysplasia.
Its value comes from placing tissue repair, metaplasia, chronic atrophy, and cancer-associated change within the same gastric context. Investigators can use this model to examine how injury-related epithelial reprogramming develops and whether persistent alterations are associated with dysplasia. This approach connects early cellular responses with later disease-relevant outcomes.
Studies of SPEM may identify biomarkers linked to epithelial reprogramming, chronic atrophy, or progression toward dysplasia. They may also highlight signaling pathways that could serve as intervention points. These findings would not by themselves establish a preventive treatment, but they can guide research into earlier detection and prevention of gastric cancer.